Andrew W. DeVilbiss

Andrew W. DeVilbiss

Auto-generated profile, based on publicly available information

Andrew W. DeVilbiss

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2021 in eLife
Verified
Journal Article
Open access
ADAndrew W DeVilbiss
Andrew W DeVilbiss
ZZZhiyu Zhao
Zhiyu Zhao
MMMisty S Martin-Sandoval
Misty S Martin-Sandoval
JUJessalyn M Ubellacker
Jessalyn M Ubellacker
ATAlpaslan Tasdogan
Alpaslan Tasdogan
SMSean J Morrison
Sean J Morrison
Little is known about the metabolic regulation of rare cell populations because most metabolites are hard to detect in small numbers of cells. We previously described a method for metabolomic profiling of flow cytometrically isolated hematopoietic stem cells (HSCs) that detects 60 metabolites in 10,000 cells (Agathocleous et al., 2017). Here we describe a new method involving hydrophilic liquid interaction chromatography and high-sensitivity orbitrap mass spectrometry that detected 160 metabolites in 10,000 HSCs, including many more glycolytic and lipid intermediates. We improved chromatographic separation, increased mass resolution, minimized ion suppression, and eliminated sample drying. Most metabolite levels did not significantly change during cell isolation. Mouse HSCs exhibited increased glycerophospholipids relative to bone marrow cells and methotrexate treatment altered purine biosynthesis. Circulating human melanoma cells were depleted for purine intermediates relative to subcutaneous tumors, suggesting decreased purine synthesis during metastasis. These methods facilitate the routine metabolomic analysis of rare cells from tissues.

28 February 2022 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
CMCorbin E. Meacham
Corbin E. Meacham
ADAndrew W. DeVilbiss
Andrew W. DeVilbiss
SMSean J. Morrison
Sean J. Morrison

1 August 2016 in Cell Reports
Verified
Journal Article
Open access
KKKoichi R. Katsumura
Koichi R. Katsumura
IOIrene M. Ong
Irene M. Ong
ADAndrew W. DeVilbiss
Andrew W. DeVilbiss
RSRajendran Sanalkumar
Rajendran Sanalkumar
EBEmery H. Bresnick
Emery H. Bresnick
The master regulatory transcription factor GATA-2 triggers hematopoietic stem and progenitor cell generation. GATA2 haploinsufficiency is implicated in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), and GATA2 overexpression portends a poor prognosis for AML. However, the constituents of the GATA-2-dependent genetic network mediating pathogenesis are unknown. We described a p38-dependent mechanism that phosphorylates GATA-2 and increases GATA-2 target gene activation. We demonstrate that this mechanism establishes a growth-promoting chemokine/cytokine circuit in AML cells. p38/ERK-dependent GATA-2 phosphorylation facilitated positive autoregulation of GATA2 transcription and expression of target genes, including IL1B and CXCL2. IL-1β and CXCL2 enhanced GATA-2 phosphorylation, which increased GATA-2-mediated transcriptional activation. p38/ERK-GATA-2 stimulated AML cell proliferation via CXCL2 induction. As GATA2 mRNA correlated with IL1B and CXCL2 mRNAs in AML-M5 and high expression of these genes predicted poor prognosis of cytogenetically normal AML, we propose that the circuit is functionally important in specific AML contexts.

2 October 2014 in Blood
Verified
Journal Article
Closed access
PDF file
SMSkye C. McIver
Skye C. McIver
YKYoon-A Kang
Yoon-A Kang
ADAndrew W. DeVilbiss
Andrew W. DeVilbiss
COChelsea A. O’driscoll
Chelsea A. O’driscoll
JOJonathan N. Ouellette
Jonathan N. Ouellette
EBEmery H. Bresnick
Emery H. Bresnick
Key Points: Exosome complex components are endogenous suppressors of erythroid cell maturation. GATA-1 and Foxo3 transcriptionally repress exosome complex components, thus abrogating the erythroid maturation blockade.

1 February 2022 in Genes & Development
Verified
Journal Article
Open access
PDF file
PZPei Zhu
Pei Zhu
NHNoah X. Hamlish
Noah X. Hamlish
ATAbhishek Vijay Thakkar
Abhishek Vijay Thakkar
ASAdam W.T. Steffeck
Adam W.T. Steffeck
EREmily J. Rendleman
Emily J. Rendleman
CPClara B. Peek
Clara B. Peek
The process of tissue regeneration occurs in a developmentally timed manner, yet the role of circadian timing is not understood. Here, we identify a role for the adult muscle stem cell (MuSC)-autonomous clock in the control of muscle regeneration following acute ischemic injury. We observed greater muscle repair capacity following injury during the active/wake period as compared with the inactive/rest period in mice, and loss of Bmal1 within MuSCs leads to impaired muscle regeneration. We demonstrate that Bmal1 loss in MuSCs leads to reduced activated MuSC number at day 3 postinjury, indicating a failure to properly expand the myogenic precursor pool. In cultured primary myoblasts, we observed that loss of Bmal1 impairs cell proliferation in hypoxia (a condition that occurs in the first 1–3 d following tissue injury in vivo), as well as subsequent myofiber differentiation. Loss of Bmal1 in both cultured myoblasts and in vivo activated MuSCs leads to reduced glycolysis and premature activation of prodifferentiation gene transcription and epigenetic remodeling. Finally, hypoxic cell proliferation and myofiber formation in Bmal1-deficient myoblasts are restored by increasing cytosolic NAD+. Together, we identify the MuSC clock as a pivotal regulator of oxygen-dependent myoblast cell fate and muscle repair through the control of the NAD+-driven response to injury.

9 July 2013 in Cold Spring Harbor Perspectives in Medicine
Verified
Journal Article
Open access
PDF file
KKKoichi R. Katsumura
Koichi R. Katsumura
ADAndrew W. DeVilbiss
Andrew W. DeVilbiss
NPNathaniel J. Pope
Nathaniel J. Pope
KJKirby D. Johnson
Kirby D. Johnson
EBEmery H. Bresnick
Emery H. Bresnick
The physiological switch in expression of the embryonic, fetal, and adult β-like globin genes has garnered enormous attention from investigators interested in transcriptional mechanisms and the molecular basis of hemoglobinopathies. These efforts have led to the discovery of cell type-specific transcription factors, unprecedented mechanisms of transcriptional coregulator function, genome biology principles, unique contributions of nuclear organization to transcription and cell function, and promising therapeutic targets. Given the vast literature accrued on this topic, this article will focus on the master regulator of erythroid cell development and function GATA-1, its associated proteins, and its frontline role in controlling hemoglobin synthesis. GATA-1 is a crucial regulator of genes encoding hemoglobin subunits and heme biosynthetic enzymes. GATA-1-dependent mechanisms constitute an essential regulatory core that nucleates additional mechanisms to achieve the physiological control of hemoglobin synthesis.